This clinical trial was performed in Shahid Sadoughi Hospital in Yazd, Iran as a referral center for admission and hospitalization of patients with Covid 19 from 14/6/2020 to 20/8/2020. After reviewing and approving the research proposal in the ethics committee of Shahid Sadoughi University of Medical Sciences of Yazd (Code: IR.SSU.REC.1399.030), it was registered in the Iranian Clinical Trials Register System (IRCT) )https://en.irct.ir/trial/48218). Sampling was done by census method from 7 active wards of the hospital in the field of Covid-19 based on inclusion and exclusion criteria.
Inclusion criteria were: positive Covid-19 PCR test, age 10 to 70 years, having a healthy outer ear (no abnormalities or evidence of infection), sleep quality score above 5.
Exclusion criteria were: history of anxiety or depression, use of psychiatric drugs, having a pacemaker-platinum or any metal object in the body based on the participants' self-declaration. Sleep quality was assessed and determined based on the Pittsburgh questionnaire. Participants in the study included 70 patients with a definitive diagnosis of Covid-19 out of 115 patients admitted at the time of the study who met the inclusion criteria. All participants in the study or their guardians received informed written consent after giving full explanations about the type and manner of the study and the benefits and complications of the method used and assurance about the confidentiality of their information. Then, according to the table of random numbers, the participants were divided into two groups of intervention and control (n = 35 / each). For all participants, before the intervention, the number of coughs and the number of days of shortness of breath per day and the amount of SPO2 were recorded by the researcher. The instrument used to measure sleep quality was the Pittsburgh Sleep Questionnaire (PSQI). This questionnaire basically has 9 items, but because question 5 contains 10 sub-items, so the whole questionnaire has 19 items. Scoring is scored on a 4-point Likert scale from 0 to 3. This questionnaire has 7 subscales which are: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, daytime dysfunction.
A score higher than or equal to 5 indicates poor sleep quality. This questionnaire has high validity and 87% reliability (14, 15). The above information was collected from each participant in a quiet and private environment (with the coordination of the head of the department) for a period of 15 to 20 minutes according to the general condition of the participants.
In the next step, in the case group, after disinfecting the ear with 70% alcohol and drying the desired points(Thymus gland, Adrenal, lung 1&2, Throat, internal nose, larynx, Trachea, (left) and Shenmen, zero point, thalamus point, Anxiety point, sensorial, vital signs, insomnia (right) )Fig. 1)), each point was electrically stimulated for 15 seconds by the II POINTER EXCEL device(Serial number 9292124 Scotland, HZ16, IND.COTENS PLUS China).
After auriculotherapy, vaccaria seeds were placed on the desired points. The seeds were on the ear for seven days and patients were instructed to press the seeds 8 times a day for one minute each time for 7 days (16, 17). No special intervention was performed in the control group. It is noteworthy that the routine treatments of Covid-19 in both groups were continued according to the treatment of the infectious disease specialist of the hospital (including tablets: Kaletra, hydrochloroquine, acetaminophen and serum therapy). If patients were discharged during treatment, follow-up would be by telephone. The studied variables (number of cough, frequency of shortness of breath per day, SPO2, sleep quality) in both groups were measured and re-measured by the researcher four weeks after the intervention. The intervention was performed by a skilled researcher using auriculotherapy method and under the supervision of a clinical therapist with experience in the field of neuroscience (auriculotherapist) and with the coordination of the infectious disease specialist.
Statistic Analysis:
Spss software version 25 was used for data analysis. The mean of quantitative variables was compared before the intervention with independent t test and after the intervention with Multivariate analysis of covariance. The comparison of before and after means in each group was performed by paired t test. A significance level of 5% was considered. Variables that were significantly different between the two groups at the beginning of the study and before the intervention (SPO2, cough, ...) were considered as confounding variables and therefore we used MANCOVA analysis method for data analysis.